Healthcare Providers
Endorse Our Statement
Are You a Patient?
Patient Profiles
Writing Guidelines
TMM Press Releases
TMM in the News
Texas Editorials
Media Contacts
About Us Learn More Take Action Sign Our Petition Donate Take Our Survey
Sativex is Moving Forward PDF Print E-mail
Wednesday, 27 September 2006

GW Pharmaceuticals recently announced they are recruiting 218 patients in European countries to participate in a second Phase III study of Sativex for the treatment of MS patients.

Sativex Phase III trials are scheduled to begin in the US around the end of this year with cancer pain patients.

Last Updated ( Thursday, 28 September 2006 )
< Prev   Next >